These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 3888388

  • 1. Randomized trial comparing vindesine plus cisplatin with vinblastine plus cisplatin in patients with non-small cell lung cancer, with an analysis of methods of response assessment.
    Kris MG, Gralla RJ, Kalman LA, Kelsen DP, Casper ES, Burke MT, Groshen S, Cibas IR, Bagin R, Heelan RT.
    Cancer Treat Rep; 1985 Apr; 69(4):387-95. PubMed ID: 3888388
    [Abstract] [Full Text] [Related]

  • 2. A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis.
    Le Chevalier T, Pujol JL, Douillard JY, Alberola V, Monnier A, Riviere A, Lianes P, Chomy P, Cigolari S, Besson F.
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):28-33; discussion 33-4. PubMed ID: 7973766
    [Abstract] [Full Text] [Related]

  • 3. Comparison of vindesine plus cisplatin or vindesine plus mitomycin in the treatment of advanced non-small cell lung cancer.
    Shinkai T, Saijo N, Tominaga K, Eguchi K, Shimizu E, Sasaki Y, Fujita J, Futami H.
    Cancer Treat Rep; 1985 Sep; 69(9):945-51. PubMed ID: 2992785
    [Abstract] [Full Text] [Related]

  • 4. Cisplatin, doxorubicin, cyclophosphamide, and vindesine combination chemotherapy for non-small cell lung cancer.
    Kelsen D, Gralla R, Stoopler M, Casper E, Cheng E, Kosloff C, Golbey R.
    Cancer Treat Rep; 1982 Feb; 66(2):247-51. PubMed ID: 7034932
    [Abstract] [Full Text] [Related]

  • 5. Cisplatin and vindesine combination chemotherapy for non-small cell lung cancer: a randomized trial comparing two dosages of cisplatin.
    Shinkai T, Saijo N, Eguchi K, Sasaki Y, Tominaga K, Sakurai M, Suga J, Miyaoka H, Sano T, Keicho N.
    Jpn J Cancer Res; 1986 Aug; 77(8):782-9. PubMed ID: 3019976
    [Abstract] [Full Text] [Related]

  • 6. [A randomized trial comparing vindesine plus cisplatin with mitomycin C, vindesine plus cisplatin in patients with advanced non-small cell lung cancer].
    Fujii M, Kiura K, Okabe K, Toki H, Kimura M.
    Gan To Kagaku Ryoho; 1987 Sep; 14(9):2676-81. PubMed ID: 2820312
    [Abstract] [Full Text] [Related]

  • 7. [Treatment of non-small cell bronchial cancer with high-dosage cisplatin and vindesine. Results of a prospective study].
    König HJ, Arnold E, Walter M, Sander U.
    Fortschr Med; 1984 Sep 06; 102(33):811-4. PubMed ID: 6090286
    [Abstract] [Full Text] [Related]

  • 8. A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer.
    Masters GA, Drinkard LC, Hoffman PC, Lane N, Watson S, Samuels BL, Bitran JD, Golomb HM, Vokes EE.
    Cancer J Sci Am; 1995 Sep 06; 1(4):288-94. PubMed ID: 9166490
    [Abstract] [Full Text] [Related]

  • 9. Vindesine: an effective agent in the treatment of non-small cell lung cancer.
    Furnas BE, Williams SD, Einhorn LH, Cobleigh MA.
    Cancer Treat Rep; 1982 Sep 06; 66(9):1709-11. PubMed ID: 7116347
    [Abstract] [Full Text] [Related]

  • 10. Vindesine (VDS) monochemotherapy for non-small cell lung cancer: a report of 45 cases.
    Luedke SL, Luedke DW, Petruska P, Broun GO, Reed G, Leavitt J.
    Cancer Treat Rep; 1982 Jun 06; 66(6):1409-11. PubMed ID: 7083243
    [Abstract] [Full Text] [Related]

  • 11. Vindesine in the treatment of squamous cell carcinoma, adenocarcinoma, and large cell carcinoma of the lung.
    Osterlind K, Hørbov S, Dombernowsky P, Rørth M, Hansen HH.
    Cancer Treat Rep; 1982 Feb 06; 66(2):305-9. PubMed ID: 7055816
    [Abstract] [Full Text] [Related]

  • 12. Combination chemotherapy with cisplatin, etoposide, and vindesine in non-small cell lung carcinoma: a clinical trial of the EORTC lung cancer working party.
    Klastersky J, Sculier JP, Nicaise C, Weerts D, Mairesse M, Libert P, Rocmans P, Michel J, Ferremans W.
    Cancer Treat Rep; 1983 Feb 06; 67(7-8):727-30. PubMed ID: 6347374
    [Abstract] [Full Text] [Related]

  • 13. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G, Marschke R, Camoriano JK, Sorensen JM, Sloan JA, Richardson RL.
    Cancer J Sci Am; 1997 Feb 06; 3(5):297-302. PubMed ID: 9327154
    [Abstract] [Full Text] [Related]

  • 14. Etoposide plus cisplatin followed by thoracic radiation for stage IIIB non-small cell lung cancer: MAOP study 2188.
    Lokich J, Auerbach M, Essig L, Fryer J, Fryer D.
    J Infus Chemother; 1995 Feb 06; 5(2):70-2. PubMed ID: 8521238
    [Abstract] [Full Text] [Related]

  • 15. Study of cisplatin-vinblastine plus amifostine in patients with locally advanced or metastatic non-small cell lung cancer.
    Thongprasert S, Chewaskulyong B.
    J Med Assoc Thai; 2004 Oct 06; 87(10):1162-7. PubMed ID: 15560691
    [Abstract] [Full Text] [Related]

  • 16. Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: a prospective randomized phase III trial of the G.O.I.M. (Gruppo Oncologico Italia Meridionale).
    Gebbia V, Galetta D, Lorusso V, Caruso M, Verderame F, Pezzella G, Borsellino N, Durini E, Valenza R, Agostara B, Colucci G, Gruppo Oncologico Italia Meridionale.
    Lung Cancer; 2008 Sep 06; 61(3):369-77. PubMed ID: 18308419
    [Abstract] [Full Text] [Related]

  • 17. Adjuvant vinorelbine and cisplatin in elderly patients: National Cancer Institute of Canada and Intergroup Study JBR.10.
    Pepe C, Hasan B, Winton TL, Seymour L, Graham B, Livingston RB, Johnson DH, Rigas JR, Ding K, Shepherd FA, National Cancer Institute of Canada and Intergroup Study JBR.10.
    J Clin Oncol; 2007 Apr 20; 25(12):1553-61. PubMed ID: 17442999
    [Abstract] [Full Text] [Related]

  • 18. Phase II evaluation of vindesine in patients with non-small cell carcinoma of the lung.
    Gralla RJ, Raphael BG, Golbey RB, Young CW.
    Cancer Treat Rep; 1979 Aug 20; 63(8):1343-6. PubMed ID: 225028
    [Abstract] [Full Text] [Related]

  • 19. Mitomycin C, vinblastine, and carboplatin regimen in patients with nonsmall cell lung cancer. A phase II trial.
    Paccagnella A, Favaretto A, Oniga F, Festi G, Lauro S, Morabito A, Ossana L, Sartore F, DePoli F, Fiorentino MV.
    Cancer; 1996 Oct 15; 78(8):1701-7. PubMed ID: 8859183
    [Abstract] [Full Text] [Related]

  • 20. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.
    Okuno SH, Mailliard JA, Suman VJ, Edmonson JH, Creagan ET, Nair S, Levitt R, Kugler JW.
    Cancer; 2002 Apr 15; 94(8):2224-31. PubMed ID: 12001121
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.